Journal
Clinical infectious diseases
Publication Date
12-17-2024
Volume
79
Issue
6
First Page
1503
Last Page
1511
Document Type
Open Access Publication
DOI
10.1093/cid/ciae410
Rights and Permissions
Curtis J Donskey, Erik R Dubberke, Nicola P Klein, Elizabeth G Liles, Katarzyna Szymkowiak, Mark H Wilcox, Jody Lawrence, Salim Bouguermouh, Haiying Zhang, Kenneth Koury, Ruth Bailey, Helen M Smith, Stephen Lockhart, Erik Lamberth, Warren V Kalina, Michael W Pride, Chris Webber, Annaliesa S Anderson, Kathrin U Jansen, William C Gruber, Nicholas Kitchin, on behalf of the CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study Group, CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection, Clinical Infectious Diseases, Volume 79, Issue 6, 15 December 2024, Pages 1503–1511, https://doi.org/10.1093/cid/ciae410. https://academic.oup.com/cid/article/79/6/1503/7740506?login=true. © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Donskey, Curtis J; Dubberke, Erik R; and et al., "CLOVER (CLOstridium difficile Vaccine Efficacy Trial) study: A phase 3, randomized trial investigating the efficacy and safety of a detoxified toxin A/B vaccine in adults 50 years and older at increased risk of Clostridioides difficile infection." Clinical infectious diseases. 79, 6. 1503 - 1511. (2024).
https://digitalcommons.wustl.edu/oa_4/4787
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
